Table 2.
Baseline characteristics of included patients
| Control (n = 636) | DE-PLAN (n = 454) | ||
|---|---|---|---|
| Age | 59.3 (6.9) | 59.3 (6.9) | |
| % women | 58.0 % | 66.5 % | |
| Weight, kg | 82.9 (15.2) | 80.8 (14.8) | |
| Body mass index, kg/m2 | 31.0 (4.7) | 31.0 (5.0) | |
| % overweight | 38.0 % | 35.0 % | |
| % obese | 55.4 % | 56.0 % | |
| Cholesterol levels, mg/dL | 213.7 (34.7) | 217.0 (34.5) | |
| Triglyceride levels, mg/dL | 124.5 (65.9) | 122.7 (60.6) | |
| Glucose levels, mg/dL | 104.6 (11.8) | 104.5 (12.4) | |
| Systolic blood pressure, mm/Hg | 134.7 (15.5) | 132.5 (14.3) | |
| Diastolic blood pressure, mm/Hg | 80.9 (9.6) | 80.4 (8.8) | |
| % elevated blood pressure | 10.5 % | 10.8 % | |
| % smokers | 13.2 % | 12.6 % | |
| Co-morbidity (%) | |||
| 0 | 16.6 % | 15.7 % | |
| 1 | 32.7 % | 30.3 % | |
| 2 | 24.4 % | 25 % | |
| 3 | 14.2 % | 13.7 % | |
| 4 or more | 12.1 % | 15.3 % | |
DE-PLAN Diabetes in Europe – Prevention using Lifestyle, Physical Activity and Nutritional-intervention